McLennan SV - Search Results

1

Duration of ischaemia determines matrix metalloproteinase-2 activation in the reperfused rabbit heart.

Prasan AM, McCarron HC, White MY, McLennan SV, Tchen AS, Hambly BD, Jeremy RW. Prasan AM, et al. Among authors: mclennan sv. Proteomics. 2002 Sep;2(9):1204-10. doi: 10.1002/1615-9861(200209)2:9<1204::AID-PROT1204>3.0.CO;2-K. Proteomics. 2002. PMID: 12362337

2

Effect of glucose on matrix metalloproteinase activity in mesangial cells.

McLennan SV, Yue DK, Turtle JR. McLennan SV, et al. Nephron. 1998;79(3):293-8. doi: 10.1159/000045052. Nephron. 1998. PMID: 9678429

3

High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation.

McLennan SV, Martell SY, Yue DK. McLennan SV, et al. Diabetologia. 2000 May;43(5):642-8. doi: 10.1007/s001250051353. Diabetologia. 2000. PMID: 10855539

4

Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.

McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE. McLennan SV, et al. Diabetologia. 2002 Feb;45(2):268-75. doi: 10.1007/s00125-001-0730-4. Diabetologia. 2002. PMID: 11935159

5

Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.

McLennan SV, Martell SK, Yue DK. McLennan SV, et al. Diabetes. 2002 Aug;51(8):2612-8. doi: 10.2337/diabetes.51.8.2612. Diabetes. 2002. PMID: 12145178

6

Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.

McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM. McLennan SV, et al. Endocrinology. 2004 Dec;145(12):5646-55. doi: 10.1210/en.2004-0436. Epub 2004 Sep 2. Endocrinology. 2004. PMID: 15345671

7

2-Methoxy-2,4-diphenyl-3(2H)-furanone-labeled gelatin zymography and reverse zymography: a rapid real-time method for quantification of matrix metalloproteinases-2 and -9 and tissue inhibitors of metalloproteinases.

Min D, Lyons JG, Jia J, Lo L, McLennan SV. Min D, et al. Among authors: mclennan sv. Electrophoresis. 2006 Feb;27(2):357-64. doi: 10.1002/elps.200500484. Electrophoresis. 2006. PMID: 16331585

8

Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers.

Liu Y, Min D, Bolton T, Nubé V, Twigg SM, Yue DK, McLennan SV. Liu Y, et al. Among authors: mclennan sv. Diabetes Care. 2009 Jan;32(1):117-9. doi: 10.2337/dc08-0763. Epub 2008 Oct 3. Diabetes Care. 2009. PMID: 18835949 Free PMC article.

9

Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy.

Min D, Lyons JG, Bonner J, Twigg SM, Yue DK, McLennan SV. Min D, et al. Among authors: mclennan sv. Am J Physiol Renal Physiol. 2009 Nov;297(5):F1229-37. doi: 10.1152/ajprenal.00074.2009. Epub 2009 Sep 9. Am J Physiol Renal Physiol. 2009. PMID: 19741020 Free article.

10

Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis.

Calabro SR, Maczurek AE, Morgan AJ, Tu T, Wen VW, Yee C, Mridha A, Lee M, d'Avigdor W, Locarnini SA, McCaughan GW, Warner FJ, McLennan SV, Shackel NA. Calabro SR, et al. Among authors: mclennan sv. PLoS One. 2014 Jul 30;9(7):e90571. doi: 10.1371/journal.pone.0090571. eCollection 2014. PLoS One. 2014. PMID: 25076423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters